The Burden of Soaring Prices of Specialty Drugs
Even as the cost of prescription drugs has plummeted for many Americans, a small slice of the population is being asked to shoulder more and more of the cost of expensive treatments for diseases like cancer and hepatitis C, according to a report to be released on Tuesday by a major drug research firm.
Sebelius: Healthcare Launch 'Terribly Flawed'
The Obama administration's timeline for having ready the new healthcare law's online sign-up system "was just flat out wrong," outgoing Health and Human Services Secretary Kathleen Sebelius said in an interview that aired Sunday.
Data May Help Curb Healthcare Cost
Healthcare experts have officially begun a long-awaited dive into newly released data showing how much doctors charge and receive for treating Medicare patients.
New ASCO Guidelines for the Care of Cancer Survivors
The American Society of Clinical Oncology (ASCO) today issued three evidence-based clinical practice guidelines on the prevention and management of symptoms that affect many cancer survivors—neuropathy, fatigue and depression, and anxiety. The guidelines are the first three in a planned series of guidelines on survivorship care. The recommendations reinforce the need to care for the both physical and psychological needs of cancer survivors.
AJMC: Adler-Milstein to Serve as Guest Editor of Annual HIT Issue
Julia Adler-Milstein, an assistant professor at the University of Michigan who has published extensively on the adoption of health information technology (HIT), will serve as guest editor for the annual issue of The American Journal of Managed Care devoted to HIT. The issue will publish in September 2014.
ESTRO: ADT Plus Radiotherapy Improve Prostate Cancer Outcomes
Professor Vincenzo Valentini, president of ESTRO and a radiation oncologist at the Policlinico Universitario A. Gemelli, Rome, Italy, commented in a statement: “The results from this trial are important and practice-changing. It is clear that an additional six months of hormonal treatment in addition to radiotherapy improves the outcome for men with localised prostate cancer. This option should now be considered for all these men with prostate cancer that is at risk of growing and spreading.”
Diabetes A Significant Barrier to Breast Cancer Screening
Women with diabetes are 14 percent less likely to be screened for breast cancer compared to women without diabetes, according to a study. "Managing the demands of a chronic condition such as diabetes is challenging for many women, leaving other preventative actions, like screening for cancer, to fall by the wayside," said a physician and author. "Our study found having diabetes posed a significant barrier to breast cancer screening even after considering a woman's socioeconomic status, a known contributor to disparities in care among women."
With New Health Law, Insurers Target Diabetics
As hundreds of thousands of diabetics get health coverage under the federal law, insurance companies are aggressively targeting this glut of new patients, who are expensive to treat and often lax in taking medications and following their diet.
HHS Secretary Kathleen Sebelius Resigns
HHS Secretary Kathleen Sebelius has resigned her post barely a week after the close of the tumultuous initial open-enrollment period for the healthcare reform law's insurance exchanges.
AJMC Peer Exchange: Nationwide, Patient-Centered Strategy Needed to Battle Obesity, Type 2 Diabetes
Fighting the nation’s related epidemics of obesity and type 2 diabetes mellitus will take a nationwide strategy that increasingly tailors treatment to individual patient needs, and new approaches are need to get patients to take medications and make lifestyle changes to be healthier. That was the consensus of an expert panel convened Thursday by The American Journal of Managed Care to open its two-day conference, “Patient-Centered Diabetes Care: Putting Theory into Practice,” which is taking place at the Princeton Marriott at Forrestal. The conference continues today, opening with a keynote address by Robert A. Gabbay, MD, chief medical officer at the Joslin Diabetes Center, Harvard Medical School.